Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07400718
Eligibility Criteria:
Inclusion Criteria:
* Patients will be entered into this study only if they meet all of the following criteria:
1. Written and signed informed consent obtained before starting any protocol-specific procedures.
2. Subjects willing to withhold antihistamines, Leukotriene antagonists and H2 antagonists for at least 1 week before testing to avoid masking the histamine reactions on the skin.
3. Male or female between 18 to 60 65 years, inclusive.
4. Ability to comply with the study procedures and visit schedule.
Exclusion Criteria:
* Patients will NOT be entered into this study if they meet any of the following criteria:
1. Anaphylactic reaction (constitutional) after the previous skin test with the same allergen
2. Acute fever
3. Systemic disease with acute manifestation or decompensation
4. Abnormal skin condition in the area to be tested (such as eczema sunburn condition after sunbathing)
5. Pregnancy
6. Presence of dermatographism, severe atopic dermatitis, or use of tricyclic antidepressants.
7. Current use of beta-blockers
8. Known hypersensitivity to any component of the test solutions (histamine or glycerin).
9. Participation in another clinical study within 30 days before enrollment. Participation in another clinical study within 30 days before enrollment.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07400718
Study Brief:
Protocol Section:
NCT07400718